ProteoNova, Inc.
Accelerated protein evolution technology platform (AcPET) for directed protein engineering and optimization
- Sector
- Biotech
- Headquarters
- PASADENA, CA
- Latest Form D
- $95K, Feb 2018
- Total capital
- $1.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.6M
- 2 Form D · last Feb 2018
- 105 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 8 pending · first 2018
- Rank in peer group#46 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$95K
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#46 · top 13%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Richard B. WilliamsResearcherExecutive Officer, DirectorLinked by 3 patents
- Robert R. GuerreroExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 11- PendingModular Targeted Therapeutic Agents And Methods Of Making SameUSPTOApplication 18306189
- GrantedModular Targeted Therapeutic Agents And Methods Of Making SameUSPTOUS 11,633,474
- GrantedModular Targeted Therapeutic Agents And Methods Of Making SameUSPTOUS 10,206,998
Show all 11 patent records
- Modular Targeted Therapeutic Agents And Methods Of Making SameJan 18, 2024 · Application 18306189Pending
- Modular Targeted Therapeutic Agents And Methods Of Making SameApr 25, 2023 · US 11,633,474Granted
- Modular Targeted Therapeutic Agents And Methods Of Making SameFeb 19, 2019 · US 10,206,998Granted
- GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNANov 22, 2018 · Application 15922759Pending
- GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNAMar 20, 2018 · US 9,920,453Granted
- Method For Making Targeted Therapeutic Agents Directed To Soluble TargetsMay 23, 2013 · Application 13738861Pending
- Methods For Making Hiv Vaccines And Related CompositionsApplication PCTUS2009061720Pending
- Generation Of Library Of Soluble Random Polypeptides Linked To MrnaApplication PCTUS2008053757Pending
- Method For Making Targeted Therapeutic AgentsApplication PCTUS2006000956Pending
- System And Methods For Nucleic Acid And Polypeptide SelectionApplication PCTUS2004041380Pending
- Selection And Evolution Of Nucleic Acids And PolypeptidesApplication PCTUS2002037103Pending
Related companies, and why
- Ocugenix CorpSimilar federal contract value in Biotech · null in contracts
- Neurawell Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Cognigenics, Inc.Similar federal contract value in Biotech · null in contracts
- Onyx Style Inc.Similar federal contract value in Biotech · null in contracts
- Boston Biopharma, Inc.Similar federal contract value in Biotech · null in contracts
- NED Biosystems, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .